61 related articles for article (PubMed ID: 6690060)
1. Comparison of virus reactivation, DNA base damage, and cell cycle effects in autologous human melanoma cells resistant to methylating agents.
Hayward IP; Parsons PG
Cancer Res; 1984 Jan; 44(1):55-8. PubMed ID: 6690060
[TBL] [Abstract][Full Text] [Related]
2. Relationships among cell survival, O6-alkylguanine-DNA alkyltransferase activity, and reactivation of methylated adenovirus 5 and herpes simplex virus type 1 in human melanoma cell lines.
Maynard K; Parsons PG; Cerny T; Margison GP
Cancer Res; 1989 Sep; 49(17):4813-7. PubMed ID: 2547518
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide resistance developed in a human melanoma cell line.
Boon MH; Parsons PG
Cancer Treat Rep; 1984 Oct; 68(10):1239-46. PubMed ID: 6525597
[TBL] [Abstract][Full Text] [Related]
4. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.
Godeneche D; Rapp M; Thierry A; Laval F; Madelmont JC; Chollet P; Veyre A
Cancer Res; 1990 Sep; 50(18):5898-903. PubMed ID: 2393861
[TBL] [Abstract][Full Text] [Related]
5. Cross-sensitivity of methylating agents, hydroxyurea, and methotrexate in human tumor cells of the Mer- phenotype.
Maynard K; Parsons PG
Cancer Res; 1986 Oct; 46(10):5009-13. PubMed ID: 3756862
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of O6-methylguanine repair in human normal and ataxia telangiectasia cell lines and correlation of repair capacity with cellular sensitivity to methylating agents.
Shiloh Y; Becker Y
Cancer Res; 1981 Dec; 41(12 Pt 1):5114-20. PubMed ID: 7307010
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of human cell strains having different abilities to repair O6-methylguanine in DNA to inactivation by alkylating agents including chloroethylnitrosoureas.
Scudiero DA; Meyer SA; Clatterbuck BE; Mattern MR; Ziolkowski CH; Day RS
Cancer Res; 1984 Jun; 44(6):2467-74. PubMed ID: 6722789
[TBL] [Abstract][Full Text] [Related]
8. Relationship of DNA repair phenotypes of human fibroblast and tumor strains to killing by N-methyl-N'-nitro-N-nitrosoguanidine.
Scudiero DA; Meyer SA; Clatterbuck BE; Mattern MR; Ziolkowski CH; Day RS
Cancer Res; 1984 Mar; 44(3):961-6. PubMed ID: 6692418
[TBL] [Abstract][Full Text] [Related]
9. Dependence on treatment time of melphalan resistance and DNA cross-linking in human melanoma cell lines.
Parsons PG
Cancer Res; 1984 Jul; 44(7):2773-8. PubMed ID: 6722805
[TBL] [Abstract][Full Text] [Related]
10. Properties of human melanoma cells resistant to 5-(3',3'-dimethyl-1-triazeno)imidazole-4-carboxamide and other methylating agents.
Parsons PG; Smellie SG; Morrison LE; Hayward IP
Cancer Res; 1982 Apr; 42(4):1454-61. PubMed ID: 7060019
[No Abstract] [Full Text] [Related]
11. Mutational spectra induced under distinct excision repair conditions by the 3 methylating agents N-methyl-N-nitrosourea, N-methyl-N'-nitro-N-nitrosoguanidine and N-nitrosodimethylamine in postmeiotic male germ cells of Drosophila.
Nivard MJ; Pastink A; Vogel EW
Mutat Res; 1996 Jun; 352(1-2):97-115. PubMed ID: 8676923
[TBL] [Abstract][Full Text] [Related]
12. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
Dosch J; Kaina B
Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
[TBL] [Abstract][Full Text] [Related]
13. Cycle-dependent removal of certain methylated bases from DNA of 10T1/2 cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.
Smith GJ; Grisham JW; Kaufman DG
Cancer Res; 1981 Apr; 41(4):1373-8. PubMed ID: 7214324
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of geno- and cytotoxicity of methylnitrosourea on MMR-proficient and MMR-deficient human tumor cell lines].
Tronov VA; Kramarenko II; Smirnova TD; Terekhov SM
Tsitologiia; 2006; 48(1):19-27. PubMed ID: 16568831
[TBL] [Abstract][Full Text] [Related]
15. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines.
Branch P; Hampson R; Karran P
Cancer Res; 1995 Jun; 55(11):2304-9. PubMed ID: 7757980
[TBL] [Abstract][Full Text] [Related]
16. A mutator phenotype characterizes one of two complementation groups in human cells tolerant to methylation damage.
Aquilina G; Hess P; Fiumicino S; Ceccotti S; Bignami M
Cancer Res; 1995 Jun; 55(12):2569-75. PubMed ID: 7780970
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanine.
Pourquier P; Waltman JL; Urasaki Y; Loktionova NA; Pegg AE; Nitiss JL; Pommier Y
Cancer Res; 2001 Jan; 61(1):53-8. PubMed ID: 11196197
[TBL] [Abstract][Full Text] [Related]
18. Tetrazepinones are equally cytotoxic to Mer+ and Mer- human tumor cell lines.
Jean-Claude BJ; Mustafa A; Watson AJ; Damian Z; Vasilescu D; Chan TH; Leyland-Jones B
J Pharmacol Exp Ther; 1999 Feb; 288(2):484-9. PubMed ID: 9918549
[TBL] [Abstract][Full Text] [Related]
19. Genotoxic methylating agents modulate extracellular signal regulated kinase activity through MEK-dependent, glutathione-, and DNA methylation-independent mechanisms in lung epithelial cells.
Wichmann AE; Thomson NM; Peterson LA; Wattenberg EV
Chem Res Toxicol; 2003 Jan; 16(1):87-94. PubMed ID: 12693035
[TBL] [Abstract][Full Text] [Related]
20. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea.
Allay E; Veigl M; Gerson SL
Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
